In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine. However, both US and European cardiac arrest guidelines have not endorsed these medications due to lack of additional evidence. In this podcast we discuss the recently published VAM-IHCA trial, which evaluated vasopressin and steroids for patients with IHCA. Should we now be administering this combination of medications along with epinephrine for IHCA?
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
Ketamine is a well-known anesthetic used commonly in the ED for RSI and procedural sedation. In this podcast, we review the use of ketamine...
ICH accounts for approximately 15 percent of all strokes. Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50...
The World’s population is aging. By 2030, 20 percent of the US population will be over the age of 65 years. Older patients have...